The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...

A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a ...

In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...

Could football players with a concussion one day be treated with a quick spray up their nose? That could be a possibility one day after a new study found that a monoclonal antibody-based nasal ...

A nighttime nasal spray may offer a new way to ease sleep apnea and lower blood pressure, according to Australian researchers ...

He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate Alzheimer’s disease under the federal agency’s expanded access ...

A Mass General Brigham-led study in preclinical models suggests that a nasal spray being tested for use in preventing Alzheimer’s disease could also reduce neuroinflammation in traumatic brain ...

The asthma medication reduces congestion in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in a ...

Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, ...

The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.